BIOTrialMed to attend MEDTECH SUMMIT 2025, exhibiting innovations in clinical trial technologies
- zhangs88
- Mar 26
- 2 min read
Bethesda, Maryland—April 8–9, 2025
BIOTrialMed, a full-service clinical research organization (CRO) providing comprehensive services from study design to commercialization, today announced its participation in the MedTech Summit 2025. The event, taking place at the University of Maryland College Park, unites industry pioneers, healthcare innovators, and decision-makers to address emerging trends and technologies revolutionizing the medical landscape.
As a trusted partner to biotech firms, pharmaceutical companies, and medical device developers worldwide, BIOTrialMed will demonstrate its expertise in delivering scalable, patient-centric clinical trial solutions across the drug development lifecycle. The company will showcase its full-service capabilities, including regulatory strategy, AI-powered patient recruitment, decentralized trial execution, and data analytics. Attendees are invited to explore tailored solutions that accelerate timelines, reduce costs, and improve trial outcomes.
“At BIOTrialMed, we pride ourselves on being a one-stop partner for innovation in pre-clinical and clinical research,” said Dr. Shane Zhang, CEO and Founder of BIOTrialMed. “The MedTech Summit is the ideal forum to share how our integrated services—from pre-clinical research to post-market surveillance—help clients navigate complexity and bring transformative therapies to patients faster. We’re eager to collaborate with peers and showcase advancements driving the future of medicine.”
This year’s summit theme, “Healthcare of the Future,” resonates deeply with BIOTrialMed’s mission to bridge cutting-edge technology with practical implementation. The company will present case studies highlighting successful global trials in oncology, endocrinology, and rare diseases, emphasizing agile strategies to meet evolving regulatory demands and diverse patient needs.
For media inquiries or to arrange a meeting during the event, contact:
James Li
VP, Business Development
BIOTrialMed
(336) 949-7611
About BIOTrialMed
A full-service CRO headquartered in Bethesda, MD, BIOTrialMed specializes in end-to-end clinical trial management, offering services for pre-clinical and clinical trial programs, including protocol design, site selection, patient recruitment, data management, and regulatory submissions. With a network of 600+ investigators and 25+ years of experience, the company accelerates development cycles for innovative therapies while ensuring compliance and patient-centricity.
Comments